News Eylea (Aflibercept) Improves Vision in Diabetic Macular Edema by Medscape • 2013/08/07 • 0 Comments Regeneron Pharmaceuticals Inc's Eylea (aflibercept) significantly improved vision in patients with diabetic macular edema (DME) compared to laser surgery in two late-stage clinical trials. Reuters Health Information Full Story →